IDiyas

For the Inventor, By the Inventor

Baltimore, MD, United States of America

Elixirgen Therapeutics, Inc.


USPTO Granted Patents = 5



Trademarks = 5

Forward Citations = 10

Loading Chart...
Loading Chart...

3 inventors (with patents filed for the assignee):

goldMedal Minoru S H Ko (5 out of 12 patents)

silverMedal Minoru SH Ko (0 patent)


5 patents:

1. 12060568 - Temperature-based transient delivery of nucleic acids and proteins to cells and tissues (2024-08-13),
2. 11421248 - Temperature-based transient delivery of nucleic acids and proteins to cells and tissues (2022-08-23),
3. 11389504 - Methods of using ZSCAN4 for rejuvenating human cells (2022-07-19),
4. 10744183 - Methods of using ZSCAN4 for rejuvenating human cells (2020-08-18),
5. 10335456 - Methods of using ZSCAN4 for rejuvenating human cells (2019-07-02),
Elixirgen Therapeutics, Inc. is a biotechnology company specializing in the development of stem cell technologies for drug discovery and regenerative medicine. With a focus on induced pluripotent stem cells (iPSCs), Elixirgen Therapeutics aims to provide innovative solutions for the pharmaceutical and healthcare industries. Their cutting-edge research and technology have the potential to revolutionize the way diseases are studied and treated.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

5 Patents

#98 in Baltimore, MD

#724 in Maryland

#50,165 in US

...
Baltimore, MD, United States of America

Elixirgen Therapeutics, Inc.

Forward Citations = 10

3 inventors:

goldMedal Minoru S H Ko (5 out of 12 patents)

silverMedal Minoru SH Ko (0 patent)

Please report any incorrect information to support@idiyas.com
Loading…